⚠ ATAI is no longer actively traded.
Data shown reflects verified historical relationships.
2 Suppliers
1 Customers
3 Debt Items
20 Related Chains
Search ATAI in the supply chain database
Create ATAI supply chain alerts
Read ATAI supply chain intel
ORANGE supply chain
NVIDIA Corporation supply chain
Amazon.com, Inc. supply chain
Johnson & Johnson supply chain
Suppliers 2
Clients 1
Debt 3
Acquisitions 0
Ownership 0
Secondary 20
AtaiBeckley Inc. Suppliers
Ticker Name Confidence Evidence
JEFFERIES-LLC
JEFFERIES-LLC
90%
Under the Sales Agreement, the Company will set the parameters for the sale of Common Stock, the number of shares of Common Stock to be issued, the dates on which such sales are anticipated to be mad…
NUALTIS
NUALTIS
90%
We recognized $0.7 million in research and development services revenue for the three months ended September 30, 2025 related to certain research and development services performed by Nualtis for its…
AtaiBeckley Inc. Customers
Ticker Name Confidence Evidence
OTSUKA
OTSUKA
85%
The revenue recognized for the nine months ended September 30, 2024 is related to our license agreement with Otsuka.
AtaiBeckley Inc. Debt Obligations
Instrument Description Confidence Evidence
ATAI-DEBT-7912
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
ATAI-DEBT-7911
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2022-12-31.
ATAI-DEBT
Debt stack $2.0M
90%
Market cache reports total debt of $2.0M.
AtaiBeckley Inc. Acquisitions
No acquisitions on record No completed or pending acquisitions found in our database for AtaiBeckley Inc..
AtaiBeckley Inc. Ownership
No ownership data on record No major institutional ownership relationships found in our database for AtaiBeckley Inc..
AtaiBeckley Inc. Extended Supply Chain Network
Ticker Name Chain Index Hops Relationship Types
RCUS
Arcus Biosciences, Inc.
100.00
2
BCYC
Bicycle Therapeutics plc
100.00
2
DYN
Dyne Therapeutics, Inc.
100.00
2
HTGC
Hercules Capital, Inc.
100.00
1
['receiving']
IRON
Disc Medicine, Inc.
100.00
2
SVRA
Savara Inc.
100.00
2
ALT
Altimmune, Inc.
100.00
2
ALEC
Alector, Inc.
100.00
2
CMPS
COMPASS Pathways plc
100.00
1
['receiving']
ENGN
enGene Therapeutics Inc.
100.00
2
VRDN
Viridian Therapeutics, Inc.
100.00
2
KURA
Kura Oncology, Inc.
100.00
2
OBIO
Orchestra BioMed Holdings, Inc.
100.00
2
MDGL
Madrigal Pharmaceuticals, Inc.
100.00
2
PHGE
BiomX Inc.
100.00
2
SGHT
Sight Sciences, Inc.
100.00
2
MAZE
Maze Therapeutics, Inc.
100.00
2
REPL
Replimune Group, Inc.
100.00
2
OTSUKA
OTSUKA
54.19
1
['receiving']
PHAT
Phathom Pharmaceuticals, Inc.
50.00
2